Clinical trial
A Prospective Study of Identifying Genomic Mutations of Multiple Primary Lung Cancers by Circulating Tumor DNA
NCT02833467 is registered in ClinicalTrials.gov with Peking University People's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective Study of Identifying Genomic Mutations of Multiple Primary Lung Cancers by Circulating Tumor DNA
- Lead sponsor
- Peking University People's Hospital
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- January 31, 2015
- Completion date
- June 30, 2021
- Enrollment
- 45 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
carcinoma, non-small-cell lung cancer, thoracic neoplasms